Exact Mass: 507.2183
Exact Mass Matches: 507.2183
Found 500 metabolites which its exact mass value is equals to given mass value 507.2183
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tyr-Tyr-Tyr
Phe Val Gln Asp
Val Gln Phe Asp
Asn Phe Ile Asp
Ala Met Met Arg
Ala Met Arg Met
Ala Met Thr Trp
Ala Met Trp Thr
Ala Arg Met Met
Ala Thr Met Trp
Ala Thr Trp Met
Ala Trp Met Thr
Ala Trp Thr Met
Cys Glu Arg Thr
Cys Glu Thr Arg
Cys Ile Ser Trp
Cys Ile Trp Ser
Cys Leu Ser Trp
Cys Leu Trp Ser
Cys Met Arg Val
Cys Met Val Arg
Cys Arg Glu Thr
Cys Arg Met Val
Cys Arg Thr Glu
Cys Arg Val Met
Cys Ser Ile Trp
Cys Ser Leu Trp
Cys Ser Trp Ile
Cys Ser Trp Leu
Cys Thr Glu Arg
Cys Thr Arg Glu
Cys Thr Val Trp
Cys Thr Trp Val
Cys Val Met Arg
Cys Val Arg Met
Cys Val Thr Trp
Cys Val Trp Thr
Cys Trp Ile Ser
Cys Trp Leu Ser
Cys Trp Ser Ile
Cys Trp Ser Leu
Cys Trp Thr Val
Cys Trp Val Thr
Asp Phe Ile Asn
Asp Phe Leu Asn
Asp Phe Asn Ile
Asp Phe Asn Leu
Asp Phe Gln Val
Asp Phe Val Gln
Asp Ile Phe Asn
Asp Ile Asn Phe
Asp Leu Phe Asn
Asp Leu Asn Phe
Asp Met Arg Ser
Asp Met Ser Arg
Asp Asn Phe Ile
Asp Asn Phe Leu
Asp Asn Ile Phe
Asp Asn Leu Phe
Asp Gln Phe Val
Asp Gln Val Phe
Asp Arg Met Ser
Asp Arg Ser Met
Asp Ser Met Arg
Asp Ser Arg Met
Asp Val Phe Gln
Asp Val Gln Phe
Glu Cys Arg Thr
Glu Cys Thr Arg
Glu Phe Asn Val
Glu Phe Val Asn
Glu Lys Met Thr
Glu Lys Thr Met
Glu Met Lys Thr
Glu Met Thr Lys
Glu Asn Phe Val
Glu Asn Val Phe
Glu Arg Cys Thr
Glu Arg Thr Cys
Glu Thr Cys Arg
Glu Thr Lys Met
Glu Thr Met Lys
Glu Thr Arg Cys
Glu Val Phe Asn
Glu Val Asn Phe
Phe Asp Ile Asn
Phe Asp Leu Asn
Phe Asp Asn Ile
Phe Asp Asn Leu
Phe Asp Gln Val
Phe Asp Val Gln
Phe Glu Asn Val
Phe Glu Val Asn
Phe Ile Asp Asn
Phe Ile Asn Asp
Phe Leu Asp Asn
Phe Leu Asn Asp
Phe Met Asn Pro
Phe Met Pro Asn
Phe Asn Asp Ile
Phe Asn Asp Leu
Phe Asn Glu Val
Phe Asn Ile Asp
Phe Asn Leu Asp
Phe Asn Met Pro
Phe Asn Asn Asn
Phe Asn Pro Met
Phe Asn Val Glu
Phe Pro Met Asn
Phe Pro Asn Met
Phe Gln Asp Val
Phe Gln Val Asp
Phe Val Asp Gln
Phe Val Glu Asn
Phe Val Asn Glu
His His Asn Thr
His His Gln Ser
His His Ser Gln
His His Thr Asn
His Asn His Thr
His Asn Thr His
His Gln His Ser
His Gln Ser His
His Ser His Gln
His Ser Gln His
His Thr His Asn
His Thr Asn His
Ile Cys Ser Trp
Ile Cys Trp Ser
Ile Asp Phe Asn
Ile Asp Asn Phe
Ile Phe Asp Asn
Ile Phe Asn Asp
Ile Met Met Asn
Ile Met Asn Met
Ile Asn Asp Phe
Ile Asn Phe Asp
Ile Asn Met Met
Ile Ser Cys Trp
Ile Ser Trp Cys
Ile Trp Cys Ser
Ile Trp Ser Cys
Lys Glu Met Thr
Lys Glu Thr Met
Lys Met Glu Thr
Lys Met Thr Glu
Lys Thr Glu Met
Lys Thr Met Glu
Leu Cys Ser Trp
Leu Cys Trp Ser
Leu Asp Phe Asn
Leu Asp Asn Phe
Leu Phe Asp Asn
Leu Phe Asn Asp
Leu Met Met Asn
Leu Met Asn Met
Leu Asn Asp Phe
Leu Asn Phe Asp
Leu Asn Met Met
Leu Ser Cys Trp
Leu Ser Trp Cys
Leu Trp Cys Ser
Leu Trp Ser Cys
Met Ala Met Arg
Met Ala Arg Met
Met Ala Thr Trp
Met Ala Trp Thr
Met Cys Arg Val
Met Cys Val Arg
Met Asp Arg Ser
Met Asp Ser Arg
Met Glu Lys Thr
Met Glu Thr Lys
Met Phe Asn Pro
Met Phe Pro Asn
Met Ile Met Asn
Met Ile Asn Met
Met Lys Glu Thr
Met Lys Thr Glu
Met Leu Met Asn
Met Leu Asn Met
Met Met Ala Arg
Met Met Ile Asn
Met Met Leu Asn
Met Met Asn Ile
Met Met Asn Leu
Met Met Gln Val
Met Met Arg Ala
Met Met Val Gln
Met Asn Phe Pro
Met Asn Ile Met
Met Asn Leu Met
Met Asn Met Ile
Met Asn Met Leu
Met Asn Pro Phe
Met Pro Phe Asn
Met Pro Asn Phe
Met Gln Met Val
Met Gln Val Met
Met Arg Ala Met
Met Arg Cys Val
Met Arg Asp Ser
Met Arg Met Ala
Met Arg Ser Asp
Met Arg Val Cys
Met Ser Asp Arg
Met Ser Arg Asp
Met Thr Ala Trp
Met Thr Glu Lys
Met Thr Lys Glu
Met Thr Trp Ala
Met Val Cys Arg
Met Val Met Gln
Met Val Gln Met
Met Val Arg Cys
Met Trp Ala Thr
Met Trp Thr Ala
Asn Asp Phe Ile
Asn Asp Phe Leu
Asn Asp Ile Phe
Asn Asp Leu Phe
Asn Glu Phe Val
Asn Glu Val Phe
Asn Phe Asp Ile
Asn Phe Asp Leu
Asn Phe Glu Val
Asn Phe Leu Asp
Asn Phe Met Pro
Asn Phe Asn Asn
Asn Phe Pro Met
Asn Phe Val Glu
Asn His His Thr
Asn His Thr His
Asn Ile Asp Phe
Asn Ile Phe Asp
Asn Ile Met Met
Asn Leu Asp Phe
Asn Leu Phe Asp
Asn Leu Met Met
Asn Met Phe Pro
Asn Met Ile Met
Asn Met Leu Met
Asn Met Met Ile
Asn Met Met Leu
Asn Met Pro Phe
Asn Asn Phe Asn
Asn Asn Asn Phe
Asn Pro Phe Met
Asn Pro Met Phe
Asn Thr His His
Asn Val Glu Phe
Asn Val Phe Glu
Pro Phe Met Asn
Pro Phe Asn Met
Pro Met Phe Asn
Pro Met Asn Phe
Pro Asn Phe Met
Pro Asn Met Phe
Pro Gln Thr Tyr
Pro Gln Tyr Thr
Pro Thr Gln Tyr
Pro Thr Tyr Gln
Pro Tyr Gln Thr
Pro Tyr Thr Gln
Gln Asp Phe Val
Gln Asp Val Phe
Gln Phe Asp Val
Gln Phe Val Asp
Gln His His Ser
Gln His Ser His
Gln Met Met Val
Gln Met Val Met
Gln Pro Thr Tyr
Gln Pro Tyr Thr
Gln Ser His His
Gln Thr Pro Tyr
Gln Thr Tyr Pro
Gln Val Asp Phe
Gln Val Phe Asp
Gln Val Met Met
Gln Tyr Pro Thr
Gln Tyr Thr Pro
Arg Ala Met Met
Arg Cys Glu Thr
Arg Cys Met Val
Arg Cys Thr Glu
Arg Cys Val Met
Arg Asp Met Ser
Arg Asp Ser Met
Arg Glu Cys Thr
Arg Glu Thr Cys
Arg Met Ala Met
Arg Met Cys Val
Arg Met Asp Ser
Arg Met Met Ala
Arg Met Ser Asp
Arg Met Val Cys
Arg Ser Asp Met
Arg Ser Met Asp
Arg Thr Cys Glu
Arg Thr Glu Cys
Arg Val Cys Met
Arg Val Met Cys
Ser Cys Ile Trp
Ser Cys Leu Trp
Ser Cys Trp Ile
Ser Cys Trp Leu
Ser Asp Met Arg
Ser Asp Arg Met
Ser His His Gln
Ser His Gln His
Ser Ile Cys Trp
Ser Ile Trp Cys
Ser Leu Cys Trp
Ser Leu Trp Cys
Ser Met Asp Arg
Ser Met Arg Asp
Ser Gln His His
Ser Arg Asp Met
Ser Arg Met Asp
Ser Trp Cys Ile
Ser Trp Cys Leu
Ser Trp Ile Cys
Ser Trp Leu Cys
Thr Ala Met Trp
Thr Ala Trp Met
Thr Cys Glu Arg
Thr Cys Arg Glu
Thr Cys Val Trp
Thr Cys Trp Val
Thr Glu Cys Arg
Thr Glu Lys Met
Thr Glu Met Lys
Thr Glu Arg Cys
Thr His His Asn
Thr His Asn His
Thr Lys Glu Met
Thr Lys Met Glu
Thr Met Ala Trp
Thr Met Trp Ala
Thr Asn His His
Thr Pro Gln Tyr
Thr Pro Tyr Gln
Thr Gln Pro Tyr
Thr Gln Tyr Pro
Thr Arg Cys Glu
Thr Arg Glu Cys
Thr Thr Thr Trp
Thr Thr Trp Thr
Thr Val Cys Trp
Thr Val Trp Cys
Thr Trp Ala Met
Thr Trp Cys Val
Thr Trp Met Ala
Thr Trp Thr Thr
Thr Trp Val Cys
Thr Tyr Pro Gln
Thr Tyr Gln Pro
Val Cys Met Arg
Val Cys Arg Met
Val Cys Thr Trp
Val Cys Trp Thr
Val Asp Phe Gln
Val Asp Gln Phe
Val Glu Phe Asn
Val Glu Asn Phe
Val Phe Asp Gln
Val Phe Glu Asn
Val Phe Asn Glu
Val Phe Gln Asp
Val Met Cys Arg
Val Met Met Gln
Val Met Gln Met
Val Met Arg Cys
Val Asn Glu Phe
Val Asn Phe Glu
Val Gln Asp Phe
Val Gln Met Met
Val Arg Cys Met
Val Arg Met Cys
Val Thr Cys Trp
Val Thr Trp Cys
Val Trp Cys Thr
Val Trp Thr Cys
Trp Ala Met Thr
Trp Ala Thr Met
Trp Cys Ile Ser
Trp Cys Leu Ser
Trp Cys Ser Ile
Trp Cys Ser Leu
Trp Cys Thr Val
Trp Cys Val Thr
Trp Ile Cys Ser
Trp Ile Ser Cys
Trp Leu Cys Ser
Trp Leu Ser Cys
Trp Met Ala Thr
Trp Met Thr Ala
Trp Ser Cys Ile
Trp Ser Cys Leu
Trp Ser Ile Cys
Trp Ser Leu Cys
Trp Thr Ala Met
Trp Thr Cys Val
Trp Thr Met Ala
Trp Thr Thr Thr
Trp Thr Val Cys
Trp Val Cys Thr
Trp Val Thr Cys
Tyr Pro Gln Thr
Tyr Pro Thr Gln
Tyr Gln Pro Thr
Tyr Gln Thr Pro
Tyr Thr Pro Gln
Tyr Thr Gln Pro
N-(4(4-PIPERIDINOMETHYL) PYRIDYL-2-OXY)-CIS-2-BUTENE)PHTALMIDE MALEATE
2-(2,4-Bis(tert-pentyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)butyramide
EMA401
Olodanrigan (EMA401) is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. It is under development as a neuropathic pain therapeutic agent. Olodanrigan (EMA401) analgesic action appears to involve inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons[1][2][3][4].
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5R,6S)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5R,6R)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid
(2R)-2-acetamido-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[(1R,2R)-2-hydroxy-1-[[(2S,4R)-4-propylpyrrolidine-2-carbonyl]amino]propyl]oxan-2-yl]sulfanylpropanoic acid
N-[4-[[2-methoxy-5-[4-oxo-3-(phenylmethyl)-1,2-dihydroquinazolin-2-yl]phenyl]methoxy]phenyl]acetamide
Asn-Leu-Phe-Asp
A tetrapeptide composed of L-asparagine, L-leucine, L-phenylalanine and L-aspartic acid joined in sequence by peptide linkages.
(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(1-methylimidazol-4-yl)sulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(1-methylimidazol-4-yl)sulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-[(1-methyl-4-imidazolyl)sulfonyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[(1-methyl-4-imidazolyl)sulfonyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide
(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
1-[[(4R,5S)-8-(2-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
1-[[(4R,5S)-8-(2-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
1-[[(4R,5R)-8-(2-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[(1-methyl-4-imidazolyl)sulfonyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide
1-[[(4S,5R)-8-(2-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
1-[[(4S,5S)-8-(2-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
1-[[(4R,5R)-8-(2-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
1-[[(4S,5S)-8-(2-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
1-[[(4S,5R)-8-(2-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide
[(1S)-2-[(3-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-cyclopropylmethanone
(1r,2r,4s,6s,7s,9s,10s,11s,12r,13s,14r)-2,4,6,9,11,13,14-heptahydroxy-11-isopropyl-7,10-dimethyl-3-methylidene-15-oxapentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan-12-yl 1h-pyrrole-2-carboxylate
(1'r,2s,2'r,6's,7's,9's,10's,11's,12'r,13's,14'r)-2',6',9',11',13',14'-hexahydroxy-11'-isopropyl-7',10'-dimethyl-15'-oxaspiro[oxirane-2,3'-pentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan]-12'-yl 1h-pyrrole-2-carboxylate
(13s)-8,9-dehydro-18-hydroxy-10-epi-ryanodine
{"Ingredient_id": "HBIN001300","Ingredient_name": "(13s)-8,9-dehydro-18-hydroxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4930","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20-norspiganthine-5-carboxylicacid
{"Ingredient_id": "HBIN003424","Ingredient_name": "20-norspiganthine-5-carboxylicacid","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "CC1CCC2(C3(CC4(C5(C(C3C(C5(C(C)C)O)OC(=O)C6=CC=CN6)(C2(C1O)O4)O)C)O)C(=O)O)O","Ingredient_weight": "507.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15785","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101131109","DrugBank_id": "NA"}
6-deoxy-6β,9β-epoxy-8α-hydroxy-10-epi-ryano-dine
{"Ingredient_id": "HBIN012313","Ingredient_name": "6-deoxy-6\u03b2,9\u03b2-epoxy-8\u03b1-hydroxy-10-epi-ryano-dine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5168","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8,9-dehydro-20-hydroxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013585","Ingredient_name": "8,9-dehydro-20-hydroxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4931","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8,9-dehydro-21-hydroxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013586","Ingredient_name": "8,9-dehydro-21-hydroxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4932","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8α,9α-epoxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013613","Ingredient_name": "8\u03b1,9\u03b1-epoxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "CC(C)C1(C(C2(C3(CC4(C1(C2(C5(C3(CC6C(C5O)(O6)C)O)O4)O)C)O)C)O)OC(=O)C7=CC=CN7)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7090","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8β,9β-epoxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013655","Ingredient_name": "8\u03b2,9\u03b2-epoxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "CC(C)C1(C(C2(C3(CC4(C1(C2(C5(C3(CC(C(=C)C5O)O)O)O4)O)C)O)C)O)OC(=O)C6=CC=CN6)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7091","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}